UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medipost, LG Chem to develop stem cell therapy
by Lee Han-soo
2019-01-08 17:55
Samsung Bioepis to expand business in China
by Lee Han-soo
2019-01-07 12:30
Celltrion’s Truxima claims 35% of European rituximab market
by Lee Han-soo
2019-01-04 15:54
Alteogen wins patent on optimizing incubation conditions for Eylea biosimilar
by Lee Han-soo
2019-01-03 16:01
Newly listed pharmaceuticals suffer market cap declines
by Nam Doo-hyun
2018-12-21 15:13
라인
Celltrion Healthcare’s sell-off of domestic sales right raises window-dressing controversy
by Nam Doo-hyun
2018-12-17 12:48
Samsung BioLogics’ market cap rises after accounting issue
by Nam Doo-hyun
2018-12-13 15:33
‘Bispecific antibody market offers promising outlook’
by Nam Doo-hyun
2018-12-12 16:27
Samsung BioLogics, Celltrion shares soar despite uncertainty
by Lee Han-soo
2018-12-12 16:27
Machine learning finds biomarker for rare Castleman Disease
by Lee Hye-seon
2018-12-11 17:11
라인
Viromed finds prostate hyperplasia treatment effect in natural substance
by Lee Han-soo
2018-12-11 14:55
Samsung BioLogics resumes trading despite controversies
by Lee Han-soo
2018-12-11 10:50
Celltrion unveils clinical trial results for rituximab biosimilar in US
by Lee Han-soo
2018-12-06 11:11
Samsung BioLogics, Saint-Gobain sign supply agreement
by Lee Han-soo
2018-12-05 14:01
Chong Kun Dang launches world’s 1st 2nd-generation anemia biosimilar
by Lee Han-soo
2018-12-04 11:18
라인
‘Rules to be tougher on patent transfer due to ToolGen case’
by Nam Doo-hyun
2018-11-29 11:48
Celltrion wins FDA nod for rituximab biosimilar
by Lee Han-soo
2018-11-29 10:50
Samsung BioLogics files administrative suit to refute accounting fraud ruling
by Nam Doo-hyun
2018-11-28 15:30
Pharmaceuticals, biotechs rise with KOSPI rebound
by Nam Doo-hyun
2018-11-27 11:53
Celltrion’s Remsima tops global sale of ₩1 trillion
by Lee Han-soo
2018-11-23 14:54
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top